| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/23/2009 | CA2711912A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | CA2710374A1 Fungicide hydroximoyl-tetrazole derivatives |
| 07/22/2009 | EP2080761A1 Compounds |
| 07/22/2009 | EP2080760A1 Fused quinoline derivative and use thereof |
| 07/22/2009 | EP2079740A2 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 07/22/2009 | EP2079739A2 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| 07/22/2009 | EP2079738A2 7-azaindole derivatives as c-met kinase inhibitors |
| 07/22/2009 | EP2079737A1 Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions |
| 07/22/2009 | EP2079736A1 Substituted triazoles useful as axl inhibitors |
| 07/22/2009 | EP2079729A1 Compounds and compositions as protein kinase inhibitors |
| 07/22/2009 | EP2079728A1 N-aryl pyrazole compounds for use against diabetes |
| 07/22/2009 | EP2079724A2 Substituted pyridone compounds and methods of use |
| 07/22/2009 | EP2079721A2 Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 07/22/2009 | EP2079690A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 07/22/2009 | EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 07/22/2009 | EP1678169B1 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer |
| 07/22/2009 | EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 07/22/2009 | EP1517684B1 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101490051A Pyrido [2, 3-b] pyrazine derivatives useful as herbicidal compounds |
| 07/22/2009 | CN101490050A Pharmaceutical compounds |
| 07/22/2009 | CN101486710A Method for synthesizing 3-halogenated indolizine compound |
| 07/22/2009 | CN100516065C 1,3,4-oxadiazol-2-ones as PPAR-delta modulators |
| 07/22/2009 | CN100516064C Kinase inhibitors |
| 07/21/2009 | US7563899 Opioid antagonists; lyophilization |
| 07/21/2009 | US7563893 3-Phenyl-cinnoline analogue and antitumor agent using the same |
| 07/21/2009 | US7563890 Synthons; nanomembranes |
| 07/21/2009 | US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 07/21/2009 | US7563788 3-[2-(3-Ethyl-ureido)-7-pyridin-3-yl-imidazo[1,2-a]pyridin-5-yl]-[1,2,4]oxadiazole-5-carboxylic acid methylamide; antibiotic resistance; grampositive, gramnegative, anaerobic bacteria; otitis; sinusitis, pharyngitis/tonsilitis, bronchitis, urinary tract infections, skin infections, pneumonia, septicemia |
| 07/16/2009 | WO2009089482A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
| 07/16/2009 | WO2009089454A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 07/16/2009 | WO2009089359A1 Pyrazolopyridines as kinase inhibitors |
| 07/16/2009 | WO2009089352A1 Pyrrolopyridines as kinase inhibitors |
| 07/16/2009 | WO2009089263A2 Novel compositions and methods of use |
| 07/16/2009 | WO2009089076A2 Processes for the preparation and purification of paliperidone palmitate |
| 07/16/2009 | WO2009087225A2 Pyrrolopyrimidines and pyrrolopyridines |
| 07/16/2009 | WO2009087153A1 Tricyclic nitrogen compounds and their use as antibacterial agents |
| 07/16/2009 | WO2009087151A1 Polymorphic forms of moxifloxacin hydrochloride and processes for preparation thereof |
| 07/16/2009 | WO2009087127A1 Modulators for amyloid beta |
| 07/16/2009 | WO2009067166A3 Non-nucleoside reverse transcriptase inhibitors |
| 07/16/2009 | WO2009050183A3 Imidazo [1, 2-a] pyridine derivatives useful as alk inhibitors |
| 07/16/2009 | WO2008068171A9 Substituted pyrimidines and their use as jnk modulators |
| 07/16/2009 | US20090182142 Aromatic Compound |
| 07/16/2009 | US20090182006 Treating a respiratory disorder by administering a hydrate of Gemifloxacinwith a carrier or excipient; chemical resistance; humidity; storage stability; thermodynamics; materials handling; sksin disorders; soft tissue-targeted therapy; sexual disorders; bovine mastitis; veterinary medicine |
| 07/16/2009 | US20090182001 Inhibitors of checkpoint kinases |
| 07/16/2009 | US20090181996 Substituted quinolones iii |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181971 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 07/16/2009 | US20090181965 Modulators for amyloid beta |
| 07/16/2009 | US20090181959 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | US20090181957 Benzimidazolone derivatives as cb2 receptor ligands |
| 07/16/2009 | US20090181945 Two cyclic cinnamide compound |
| 07/16/2009 | US20090181941 Pyrrolopyrimidines and Pyrrolopyridines |
| 07/16/2009 | US20090181936 antiandrogen compounds, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in the prevention and treatment of conditions mediated by androgen receptors, such as prostrate cancer |
| 07/16/2009 | CA2727055A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
| 07/16/2009 | CA2714888A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 07/16/2009 | CA2711845A1 Pyrrolopyrimidines and pyrrolopyridines |
| 07/16/2009 | CA2711741A1 Pyrazolopyridines as kinase inhibitors |
| 07/16/2009 | CA2711614A1 Pyrrolopyridines as kinase inhibitors |
| 07/16/2009 | CA2711500A1 Novel hiv integrase inhibitors and methods of use |
| 07/16/2009 | CA2703824A1 Modulators for amyloid beta |
| 07/15/2009 | EP2078719A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 07/15/2009 | EP2078718A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 07/15/2009 | EP2078711A1 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 07/15/2009 | EP2078017A1 Fluorinated catharanthine derivatives, their preparation and their utilisation as vinca dimeric alkaloid precursors |
| 07/15/2009 | EP2078016A2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 07/15/2009 | EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/15/2009 | EP2078009A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 07/15/2009 | EP2078004A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 07/15/2009 | EP2078003A1 Anilinopiperazine derivatives and methods of use thereof |
| 07/15/2009 | EP2078002A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 07/15/2009 | EP2077998A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 07/15/2009 | EP2077837A2 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof |
| 07/15/2009 | EP2077836A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 07/15/2009 | EP2077835A2 An alzheimer's disease progression inhibitor containing heterocyclic compound |
| 07/15/2009 | EP1973912B1 Tetrabenzodiazadiketoperylene colourants in ir-reflective coatings and plastics |
| 07/15/2009 | EP1711469B1 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis |
| 07/15/2009 | CN101484454A Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 07/15/2009 | CN101484453A Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN101481376A Heterocycle-fused 14-hydroxy-morphinan compounds, preparation and use |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513407C Tricyclic delta-opioid modulators |
| 07/14/2009 | US7560547 chemical synthesis of N-[2,4-dibromo-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide; used as drugs and chemical intermediates |
| 07/14/2009 | US7560468 Substituted 1,4,8-triazaspiro[4,5]decan-2-one compounds |
| 07/14/2009 | US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/14/2009 | CA2335285C Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity |
| 07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | WO2008083357A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/09/2009 | WO2009086139A1 Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections |
| 07/09/2009 | WO2009086123A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | WO2009085983A1 5-anilinoimidazopyridines and methods of use |
| 07/09/2009 | WO2009085980A1 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents |